Unlisted
Stock Code: 228180
| Company Name | (주)비엘사이언스 |
| English Name | TCM BIOSCIENCES INC. |
| Business Reg. No. | 2208785225 |
| CEO | 신 동진 |
| Address | 경기도 성남시 분당구 판교로228번길 15, 3동 3층 (삼평동, 판교세븐벤처밸리 1) |
| Industry | 그 외 기타 의료용 기기 제조업 |
| Industry Code | 701 |
| Main Products | 의료기기 |
| Established | 20090803 |
| Phone | 031-698-3041 |
| Website | www.tcmbiosciences.com |
| Regular Employees | Contact |
| Corp. Reg. No. | 1101114150457 |
Venture Certified
| 기술평가보증기업(기금) | 2014-02-24 ~ 2016-02-23 | 20140101663 | 2014-02-24 |
| 벤처투자유형 | 2016-02-24 ~ 2018-02-23 | 20160300062 | 2014-02-24 |
| 벤처투자유형 | 2018-02-24 ~ 2020-02-23 | 20180300154 | 2014-02-24 |
| 벤처투자유형 | 2020-04-23 ~ 2022-04-22 | 20200300434 | 2014-02-24 |
| 벤처투자유형 | 2024-08-06 ~ 2027-08-05 | 20240806010012 | 2014-02-24 |
Revenue CAGR -6.7%
| Item | 2023 | 2022 |
|---|---|---|
| Revenue | 12B | 13B |
| Operating Profit | -9.7B | -17B |
| Net Profit | -13B | -18B |
| Total Assets | 59B | 100B |
| Total Liabilities | 120B | 121B |
| Total Equity | -61B | -21B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -10B
2 Consecutive Years of Net Loss
▼ 6.7%
▲ 42.3%
▲ 38.2%
▲ 66.8%
▼ 76.7%
| Name | Position | Role |
|---|---|---|
| 신 동진 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 용인시",
"ceo_name": "신동진",
"certificate": [
{
"cert_number": "20140101663",
"changes": "",
"disclosure_date": "2014-02-24",
"first_cert_date": "2014-02-24",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2014-02-24 ~ 2016-02-23"
},
{
"cert_number": "20160300062",
"changes": "",
"disclosure_date": "2016-02-25",
"first_cert_date": "2014-02-24",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2016-02-24 ~ 2018-02-23"
},
{
"cert_number": "20180300154",
"changes": "",
"disclosure_date": "2018-03-08",
"first_cert_date": "2014-02-24",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2018-02-24 ~ 2020-02-23"
},
{
"cert_number": "20200300434",
"changes": "",
"disclosure_date": "2020-04-23",
"first_cert_date": "2014-02-24",
"no": "4",
"type": "벤처투자유형",
"valid_period": "2020-04-23 ~ 2022-04-22"
},
{
"cert_number": "20240806010012",
"changes": "",
"disclosure_date": "2024-08-06",
"first_cert_date": "2014-02-24",
"no": "5",
"type": "벤처투자유형",
"valid_period": "2024-08-06 ~ 2027-08-05"
}
],
"company_name": "주식회사 비엘사이언스",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 1633235000,
"cost_of_sales": 1291928000,
"current_assets": 2012896000,
"current_liabilities": 11768169000,
"gross_profit": -27051000,
"net_income": -1815355000,
"net_income_bs": -1815355000,
"non_current_assets": 7998389000,
"non_current_liabilities": 294189000,
"non_operating_expenses": 833081000,
"non_operating_income": 702782000,
"operating_profit": -1685056000,
"revenue": 1264877000,
"sga_expenses": 1658006000,
"total_assets": 10011285000,
"total_equity": -2051073000,
"total_liabilities": 12062358000
},
"2023": {
"capital_stock": 1633235000,
"cost_of_sales": 786200000,
"current_assets": 1036969000,
"current_liabilities": 11659852000,
"gross_profit": 393355000,
"net_income": -1266370000,
"net_income_bs": -1266371000,
"non_current_assets": 4820868000,
"non_current_liabilities": 332945000,
"non_operating_expenses": 749486000,
"non_operating_income": 454594000,
"operating_profit": -971478000,
"revenue": 1179555000,
"sga_expenses": 1364833000,
"total_assets": 5857837000,
"total_equity": -6134961000,
"total_liabilities": 11992798000
}
},
"industry": "그 외 기타 의료용 기기 제조업",
"investment": [
{
"amount": "1,000,017,000",
"changes": "1,000,017,000",
"date": "2024-05-20"
},
{
"amount": "1,499,976,000",
"changes": "1,499,976,000",
"date": "2016-06-14"
}
],
"main_products": "의료기기",
"phone": "031-698-****",
"years": [
2023,
2022
]
}Data Quality: 4/10 | Primary Source: DART | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |